Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls |
| |
| Authors: | M Nankai S Yoshimoto K Narita R Takahashi |
| |
| Affiliation: | 1. Department of Mental Health, NTNU, Norwegian University of Science and Technology, Trondheim, Norway;2. Department of Psychiatry, St. Olav''s University Hospital, Trondheim, Norway;3. Department of Clinical Medicine, Section for Psychiatry, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway;4. Division of Psychiatry, Haukeland University Hospital, Bergen, Norway;5. Division of Mental Health Care, Valen Hospital, Fonna Local Health Authority, Valen, Norway;1. Department of Psychosis Studies, Institute of Psychiatry, King''s College London, UK;2. Bristol-Myers Squibb, UK;3. Centre for Neuroimaging Sciences (CNS), King''s College London, UK;4. Department of Psychological Medicine, Institute of Psychiatry, King''s College London, UK;5. NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust, King''s College London, London, UK |
| |
| Abstract: | Platelet [3H]imipramine binding was determined in 28 patients with major depression, 11 with bipolar disorders, and 28 healthy controls. The mean maximum number of binding sites (Bmax) in depressed patients was significantly lower than in healthy controls. A significant negative correlation was found between the Bmax values and the total scores of the 17-item Hamilton depression rating scale in major depression. Our results suggest that the Bmax values in major depression may be related to severity of depression. There were significant circadian variations in the Bmax values of [3H]imipramine binding on human platelets from six healthy controls. The mean Bmax values were significantly low in the dark phase and high in the light phase. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
